September 10, 2021

In Open AAA Repair, Acute Normovolemic Hemodilution Offers Advantages Over Standard Transfusions

Technique reduces blood requirements and helps normalize coagulation levels

21-HVI-2255659_blood-transfusion_650x450

Acute normovolemic hemodilution (ANH) in patients undergoing open abdominal aortic aneurysm (AAA) repair appears to reduce intra- and postoperative blood transfusion requirements, help normalize coagulation parameters and decrease hospital stay.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

According to a retrospective review of Cleveland Clinic patients published in the Journal of Vascular Surgery, ANH — a blood conservation technique that involves controlled collection and storage of patients’ whole blood shortly after induction of anesthesia — may be an improvement over standard transfusion practices for open surgical management of AAA. The technique is accompanied by intravenous infusions of crystalloids or colloids to maintain intravascular volume.

“Although acute normovolemic hemodilution has been well studied in cardiac surgery and neurosurgery, and briefly studied in a mixed cohort of vascular surgery populations, data on the technique’s utility specifically in open AAA repair are limited,” says study co-author Jarrad Rowse, MD, of Cleveland Clinic’s Department of Vascular Surgery. He notes that this study appears to be the first to evaluate the effect of ANH on use of intra- and postoperative fluids, blood components and colloids as well as its effect on coagulation function in the AAA population.

“The development of techniques designed to reduce blood loss in surgical patients continues to be a high priority, as the long-term sequelae of allogeneic blood transfusion are an ongoing source of clinical concern,” adds study co-author Jia Lin, MD, PhD, a cardiothoracic anesthesiologist at Cleveland Clinic. “However, new research shows that fewer red cells and other critical elements are lost when acute normovolemic hemodilution is employed — a benefit that can help patients maintain acceptable hematocrit levels and obviate the need for further intervention in patients undergoing open AAA repair.”

Advertisement

Study essentials

The study reviewed all 209 patients who underwent elective open AAA repair at Cleveland Clinic from 2017 to 2019. Among these, the researchers identified those who were eligible for ANH and had a hematocrit > 38%, normal ventricular function, a normal coagulation profile, and absence of cardiac ischemia, valvular disease and late-stage chronic kidney disease. Of the 76 patients who met these inclusion criteria, 27 were managed with ANH and 49 with standard transfusion practices.

Comparison of the ANH and standard transfusion groups revealed the following:

  • Allogenic packed red blood cell (PRBC) transfusion requirements were lower in the ANH group intraoperatively (P = 0.02), at 24 and 48 hours postoperatively (P = 0.008 and P = 0.007, respectively) and throughout the hospital stay (P = 0.011).
  • There were no between-group differences in intraoperative platelet or cryoprecipitate transfusions.
  • At 48 hours, ANH was associated with significantly higher platelet counts relative to standard transfusion, as well as with lower partial thromboplastin time and lower international normalized ratio (INR).
  • There were no significant differences between the groups in rates of myocardial infarction, death, return to the operating room or other clinical outcomes.
  • Hospital length of stay was shorter in the ANH group (7.0 ± 2.7 vs. 8.8 ± 4.8 days; P = 0.041).

Promising, but prospective confirmation needed

“These retrospective data show that acute normovolemic hemodilution in the setting of open AAA repair reduced intra- and postoperative transfusion requirements while improving platelet counts and INRs at 48 hours and shortening patients’ length of stay,” observes Dr. Rowse. “The fact that patients undergoing this technique showed improved postoperative coagulation parameters and significantly shorter length of stay is encouraging, as both of these are known to improve clinical outcomes.”

Advertisement

The authors write that these findings can help inform the design of a prospective randomized trial and that a multivariate analysis may provide further insights as more Cleveland Clinic patients undergo ANH. Ultimately, they note, a larger prospective investigation is needed to fully confirm the promise of ANH as a favorable blood conservation strategy for patients undergoing open AAA repair.

Related Articles

mesh stent in a carotid artery
March 28, 2024
Carotid Revascularization Following the New CMS Coverage Decision: How to Operationalize Policies to Prioritize Outcomes

Insights from the Cleveland Clinic experience and a multispecialty alliance

illustration of femoropopliteal bypass with the DETOUR system
January 10, 2024
Pooled 2-Year Outcomes of DETOUR Trials Support Percutaneous Transfemoral Arterial Bypass

Larger data set confirms safety, efficacy and durability for SFA lesions over 20 cm

image of human brain with an intracranial aneurysm
September 15, 2023
Intracranial Aneurysm Risk in Marfan Syndrome: Study Reveals Higher-Than-Expected Prevalence

Cleveland Clinic findings prompt efforts for broad data pooling

21-HVI-4131174-CQD-Paclitaxel-coated-devices-for-PAD
September 7, 2023
Paclitaxel-Coated Devices: How the Process of Ruling Out Safety Concerns Is Improving Vascular Surgery Research

Benefits of new FDA safety determination go beyond expanding patients’ options

imaging study of type II endoleak
August 16, 2023
Novel Approach to Transcaval Type II Endoleak Embolization Shows Safety and Efficacy

Technique features heavyweight guidewire and electrocautery to access the aortic sac

images of carotid bifurcation before and after TCAR
July 6, 2023
As CMS Mulls Broader Coverage of Carotid Stenting, Transcarotid Artery Revascularization Is Poised to Grow

A look at where TCAR and transfemoral carotid stenting are likely headed

22-HVI-3109643 carotid stent CQD 650×450
August 22, 2022
Advances Have Put Carotid Artery Stenting on Par With Surgery for Stroke Prevention

JACC review calls for CMS to update coverage decision

22-HVI-2977158_aberrant-right-subclavian-artery_650x450
June 8, 2022
Aberrant Right Subclavian Artery: When Best to Intervene?

Cleveland Clinic experience points to a symptoms- and complications-based approach

Ad